Literature DB >> 17475249

Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo.

Peter Szurman1, Ana Sierra, Radoslaw Kaczmarek, Gesine B Jaissle, Barbara Wallenfels-Thilo, Salvatore Grisanti, Matthias Lüke, Karl U Bartz-Schmidt, Martin S Spitzer.   

Abstract

Epiretinal deposits of triamcinolone acetonide (TA) can be detrimental to retinal cells in vitro as several laboratory studies have shown. This contrasts with the good clinical experience of intravitreal TA use. We investigated the effect of TA crystals on retinal cells concerning the critical dose range, a potential cell recovery, the drug-tissue interaction and what protective biological factors could explain the discrepancy between in vivo and in vitro results. A human retinal pigment epithelium cell line (ARPE19) and transformed rat retinal ganglion cells (RGC5) were used. Purified TA crystals were either added directly on top of the cell cultures or on top of membrane filter inserts, basement membrane sheets or porcine vitreous with the cells growing underneath. To determine the number of live versus dead cells fluorescent stains were used. Proliferation and viability were measured using the MTT assay and the mean inhibitory dose (ID(50)) calculated with or without a filter. Cell recovery was measured after transient TA exposure (0.01-1 mg/ml) compared to continuous exposure after 7 days. To exclude a mere mechanical effect of epicellular deposits the TA crystals were replaced by glass pearls in a serum-free medium and the MTT toxicity assay was performed after 24 h. Without direct contact of TA crystals with the cells only a moderate decrease of mitochondrial activity was observed that fully recovered after transient exposure and showed a clinically safe ID(50) of 7.7 mg/ml. In contrast, direct exposure to even minute crystalline deposits for 7 days caused a rapid progressive and irreversible cell death being significant far below clinically used concentrations (ID(50) 0.058 mg/ml). Direct exposure to glass pearls did not show any loss of viability. Both basement membrane sheets and vitreous reliably prevented direct cytotoxicity to underlying retinal ganglion cells. Our findings suggest that irreversible TA cytotoxicity in a cell culture setting occurs earlier than previously assumed in the presence of even minute epicellular deposits. But in most clinical situations epiretinal TA deposits seem not to be harmful to ocular cells as protective biological factors may prevent close apposition of TA crystals to susceptible retinal cells. However, in eyes that have undergone vitrectomy with ILM peeling epimacular deposits could be critical.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475249     DOI: 10.1016/j.exer.2007.03.003

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  11 in total

1.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 2.  A Review of the Role of Intravitreal Corticosteroids as an Adjuvant to Antibiotics in Infectious Endophthalmitis.

Authors:  Dawn Ching Wen Ho; Aniruddha Agarwal; Cecilia S Lee; Jay Chhablani; Vishali Gupta; Manoj Khatri; Jayabalan Nirmal; Carlos Pavesio; Rupesh Agrawal
Journal:  Ocul Immunol Inflamm       Date:  2016-11-16       Impact factor: 3.070

3.  [Intravitreal dexamethasone implant for treatment of persistent postoperative macular edema after vitrectomy].

Authors:  L-O Hattenbach; C Kuhli-Hattenbach; C Springer; J Callizo; H Hoerauf
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

4.  Safety of intravitreal triamcinolone acetonide: an electrophysiologic and histopathological study in rabbits.

Authors:  Laila Hassan M El-Shazly; Amal Ahmad El-Gohary; Ghada Ghanem El-Hossary
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

5.  [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling].

Authors:  G B Jaissle; K U Bartz-Schmidt; P Szurman
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

6.  The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina.

Authors:  Matthias Lüke; Kai Januschowski; Julia Lüke; Salvatore Grisanti; Peter Szurman; Klaus Dietz; Anselm Kampik; Karl Ulrich Bartz-Schmidt; Kirsten H Eibl-Lindner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-20       Impact factor: 3.117

7.  Testing the effects of the dye acid violet-17 on retinal function for an intraocular application in vitreo-retinal surgery.

Authors:  Aysegül Tura; Aizhan Alt; Christos Haritoglou; Carsten H Meyer; Toni Schneider; Salvatore Grisanti; Julia Lüke; Matthias Lüke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-14       Impact factor: 3.117

Review 8.  Visualizing vitreous in vitrectomy by triamcinolone.

Authors:  Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-20       Impact factor: 3.117

9.  Biocompatibility of the vital dye Acid Violet-17 on retinal pigment epithelial cells.

Authors:  Ayşegül Tura; Aizhan Alt; Julia Lüke; Salvatore Grisanti; Christos Haritoglou; Carsten H Meyer; Khaled Nassar; Matthias Lüke
Journal:  Clin Ophthalmol       Date:  2016-07-29

10.  The options to minimize the surgical trauma to treat ocular diabetic complications and to improve postoperative recovery and quality of life require an individualized approach.

Authors:  Wolfgang F Schrader; Tatjana Josifova
Journal:  EPMA J       Date:  2010-03-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.